Literature DB >> 18182685

A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).

Gary Luxton1, Paul J Keall, Christopher R King.   

Abstract

To facilitate the use of biological outcome modeling for treatment planning, an exponential function is introduced as a simpler equivalent to the Lyman formula for calculating normal tissue complication probability (NTCP). The single parameter of the exponential function is chosen to reproduce the Lyman calculation to within approximately 0.3%, and thus enable easy conversion of data contained in empirical fits of Lyman parameters for organs at risk (OARs). Organ parameters for the new formula are given in terms of Lyman model m and TD(50), and conversely m and TD(50) are expressed in terms of the parameters of the new equation. The role of the Lyman volume-effect parameter n is unchanged from its role in the Lyman model. For a non-homogeneously irradiated OAR, an equation relates d(ref), n, v(eff) and the Niemierko equivalent uniform dose (EUD), where d(ref) and v(eff) are the reference dose and effective fractional volume of the Kutcher-Burman reduction algorithm (i.e. the LKB model). It follows in the LKB model that uniform EUD irradiation of an OAR results in the same NTCP as the original non-homogeneous distribution. The NTCP equation is therefore represented as a function of EUD. The inverse equation expresses EUD as a function of NTCP and is used to generate a table of EUD versus normal tissue complication probability for the Emami-Burman parameter fits as well as for OAR parameter sets from more recent data.

Entities:  

Mesh:

Year:  2007        PMID: 18182685     DOI: 10.1088/0031-9155/53/1/002

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  40 in total

1.  Current role of spacers for prostate cancer radiotherapy.

Authors:  Michael Pinkawa
Journal:  World J Clin Oncol       Date:  2015-12-10

2.  Dosimetric consequences of rotational errors in radiation therapy of pediatric brain tumor patients.

Authors:  Chris Beltran; Alexander Pegram; Thomas E Merchant
Journal:  Radiother Oncol       Date:  2011-07-02       Impact factor: 6.280

3.  Treatment planning after hydrogel injection during radiotherapy of prostate cancer.

Authors:  M Pinkawa; C Bornemann; N Escobar-Corral; M D Piroth; R Holy; M J Eble
Journal:  Strahlenther Onkol       Date:  2013-07-10       Impact factor: 3.621

4.  Dosimetric effect of tissue heterogeneity for (125)I prostate implants.

Authors:  Susana Maria Oliveira; Nuno José Teixeira; Lisete Fernandes; Pedro Teles; Pedro Vaz
Journal:  Rep Pract Oncol Radiother       Date:  2014-04-16

5.  Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.

Authors:  J Uzan; A E Nahum
Journal:  Br J Radiol       Date:  2012-03-28       Impact factor: 3.039

6.  Comparison of dose distribution for head and neck cancer patients with and without dose painting escalation during radiotherapy realized with tomotherapy unit.

Authors:  Malgorzata Skorska; Tomasz Piotrowski; Adam Ryczkowski
Journal:  Br J Radiol       Date:  2017-06-23       Impact factor: 3.039

7.  A hierarchical evolutionary algorithm for multiobjective optimization in IMRT.

Authors:  Clay Holdsworth; Minsun Kim; Jay Liao; Mark H Phillips
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

8.  A computational tool for the efficient analysis of dose-volume histograms from radiation therapy treatment plans.

Authors:  Anil Pyakuryal; W Kenji Myint; Mahesh Gopalakrishnan; Sunyoung Jang; Jerilyn A Logemann; Bharat B Mittal
Journal:  J Appl Clin Med Phys       Date:  2010-01-28       Impact factor: 2.102

9.  Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicities in Patients Receiving Concurrent Chemoradiation for Lung Cancer: Results of a Single-Center Retrospective Analysis.

Authors:  Christian L Barney; Nicholas Scoville; Eric Allan; Ahmet Ayan; Dominic DiCostanzo; Karl E Haglund; John Grecula; Terence Williams; Meng Xu-Welliver; Gregory A Otterson; Jose G Bazan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-11-23       Impact factor: 7.038

10.  Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.

Authors:  Marc D Piroth; Michael Pinkawa; Richard Holy; Gabriele Stoffels; Cengiz Demirel; Charbel Attieh; Hans J Kaiser; Karl J Langen; Michael J Eble
Journal:  Radiat Oncol       Date:  2009-11-23       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.